COVID disrupted cancer screening across the UK and worldwide. Discover how late diagnoses, new technologies, and NHS reforms are reshaping early detection in 2026. COVID’s Long Shadow and the Race …
Monthly Archives
April 2022
-
-
News
The New Evidence Standards Reshaping HTA: Why the “Illusion of EBM” Now Threatens Reimbursement Decisions in Pharma, MedTech & Digital Health
Evidence-based medicine (EBM) has long been the backbone of health technology assessment (HTA). Randomised trials feed meta-analyses, guidelines inform HTA, and HTA shapes pricing, reimbursement and adoption. But the last …